Highlights of iAnthus. Will be in competition with Medmen. Recent Company Highlights
The Company recorded $3.2 million of revenues in Q1 2018.
Received a US$50 million investment from Gotham Green Partners, which management believes to be the largest investment to date by a single investor in a publicly traded U.S. cannabis operating company.
In Massachusetts, the Company's Mayflower operation received its final certificate of registration from the Department of Public Health and began operations at its 36,000 square-foot Holliston cultivation and processing facility. At the close of Q1 2018, Mayflower was cultivating 2,670 plants, representing 15 different strains.
In Florida, the Company signed leases for dispensary locations in West Palm Beach, Orlando, Tampa Bay, and Deerfield Beach.
In New York, the Company acquired 8.5 acres of land for a planned 39,500 square-foot modular cultivation and processing facility; and signed a lease on the Company's flagship 2,000 square-foot dispensary in Brooklyn.
This is iAnthus, Similiar to Medmen but 1/6 the Market Cap. UP 75% THIS YEAR. If you wont to diversify then take a look at iAnthus. Ticker IAN / ITHUF